Ian R. Broadhurst

Rathbone Investment Management Ltd. (RIM) is an investment management firm headquartered in Liverpool, UK. The firm was founded in 1979 and is a wholly-owned subsidiary of Rathbone Brothers Plc (LSE: RAT). RIM manages portfolios for US resident individuals, trusts, charities and pensions. They also provide individual investment and wealth management services for private clients, charities, trustees and professional partners, primarily in Great Britain.

Adelphi Capital LLP is the alternative investment management subsidiary of Adelphi Capital Management Ltd. in Great Britain. The firm was founded in 1997 by Roderick Jack and Marcel Jongen. Headquartered in London, Adelphi Capital provides investment advice on a discretionary basis to onshore and offshore private investment funds that are offered to high net-worth, financially sophisticated, individual and institutional investors.

Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom.

LGT Wealth Management UK LLP (LGT WM UK) is the wealth management subsidiary of LGT UK Holdings Ltd., which is owned by LGT Group Foundation (LGT) in Liechtenstein. Previously known as Vestra Wealth LLP and as LGT Vestra LLP, the firm was founded in 2007 by Matthew Evans, Andrew Sims, David Scott and Ben Snee. In June 2016, LGT owned by the Princely Family of Liechtenstein took a majority stake in the firm, primarily from external investors in the firm. In October 2020, LGT completed the acquisition by buying the remaining equity previously held by the executive partners of LGT WM UK. Headquartered in London, LGT WM UK provides wealth management services to private clients, companies, trusts, charities and financial intermediaries based predominately in the UK and the European Economic Area (EEA).

Parkwalk Advisors Ltd. provides investment advisory services. The company was founded by Alastair Kilgour in 2009 and is headquartered in London, the United Kingdom.

Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom.

Union Bancaire Privée Geneva is a Swiss private bank that offers a wide range of high-quality investment solutions to private and institutional clients. The Swiss company provides asset allocation based on the latest macroeconomic updates, specific risk profiles, and reference currencies. The private company's macroeconomic views, asset-class outlook, and asset allocation grids are published on a monthly basis. UBP also offers structured product services to transform investment ideas into feasible investment solutions.

Investec Wealth & Investment Ltd. (IW&I) is an asset management firm headquartered in London, UK. Formerly known as Rensburg Sheppards, the firm has roots dating back to 1827. In 2023, Rathbones Group Plc (LON: RAT) acquired the firm from Investec Plc (LON: INVP, ADR: IVTJY) in Great Britain. IW&I provides a range of investment management and financial planning services for individual clients, charities, trusts and clients of professional advisers on a bespoke basis.

PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.

Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom.

Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.

Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom.

First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom.

Oxford Quantum Circuits Ltd. engages in quantum research. Its research includes research stories, major themes, and impacts. The company was founded by Peter James Leek on June 5, 2017 and is headquartered in Oxford, the United Kingdom.

Inflowmatix Ltd. designs and implements electronic systems that provide water flow and system health analytics to water utilities worldwide. It offers leakage and burst prevention solutions, pressure management and starter kit. The company was founded by Ivan Stoianov, Kelsey Lynn Skinner and David Gareth Parker on May 1, 2015 and is headquartered in Hampshire, the United Kingdom.

Echopoint Medical Ltd. provides medical devices which focused on transforming precision diagnosis and treatment of cardiovascular diseases. Its products include iKOs Microcatheter, iKOs Guidewire, IKOptika Imaging, and iKOtrak 3D Tracking. The company was founded by Adrien Desjardins, Malcolm Finlay, Ioannis Papakonstantinou, and Richard Colchester and is headquartered in London, the United Kingdom.

Symetrica Security Ltd. provides advanced isotope detection and identification technologies for the homeland security market. The firm works with contractors and government agencies to design, develop, test and deploy detection equipment for use by law enforcement personnel, customs officers, the emergency services, military personnel and first responders. The company was founded by David Ramsden, Grant Crossingham, Matthew Dallimore and Brian George Lever in 2002 and is headquartered in Southampton, the United Kingdom.

Fuel 3D Technologies Ltd. develops and manufactures 3D scanning systems and solutions. The company was founded by Ronald Daniel and James A. Peterson in 2014 and is headquartered in Oxford, the United Kingdom.

Cambridge Touch Technologies Ltd. engages in the development of software technology innovation services. Its product features includes flexible and foldable. low power, pressure sensitive, multi-touch, scalable to any size, easy to manufacture, solid state and robust, low cost, and wide temperature range. The company was founded by Corbin Church and Arokia Nathan in 2011 and is headquartered in Cambridge, the United Kingdom.

Aqdot Ltd. develops novel fabrication technology for smart capsules. Its technology simplifies the encapsulation process by utilizing the novel one-step, "shrink-wrap" approach based on a combination of emulsion technology and supramolecular chemistry. The company was founded by Jing Zhang, Chris Abell, Oren Scherman, and Roger Coulston in 2012 and is headquartered in Cambridge, the United Kingdom.

Part of Avacta Group Plc, Aptuscan Ltd. provides biotechnology research in the development of various products. The company is based in Leeds, UK. Aptuscan was acquired by Avacta Group Plc on January 10, 2012 for $2.50 million.

GaitQ Ltd. is a British company that develops wearable medical technologies for mobility enablement in Parkinson's. The company is based in Cumnor Hill, UK. The company's main product is a discreet vibrational cueing system that helps people with Parkinson's to maintain a more fluid and stable gait. The company was founded by Dongli Li, James Cantley, and André Hallack, and the CEO is William Tristan Collins.

Spectral Edge Ltd. develops image fusion technology. Its products include PHUSION for photography, multispectral vision and video personalization. The company was founded by Robert Edward Meredith Swann, David Connah, Graham D. Finlayson, Mark S. Drew and Joita Dey in February 2011 and is headquartered in Cambridge, the United Kingdom.